SCHEMBL7375633

SCHEMBL7375633

NC(=O)c1ccc2[nH]c(N3CCCCC3)cc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 2/20 0.50
GAA P10253 5/20 0.46
ALDH1A1 P00352 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
PKM P14618 1/20 0.46
HPN P05981 2/20 0.46
ST14 Q9Y5Y6 2/20 0.46
PLAU P00749 1/20 0.46
MMP2 P08253 1/20 0.45
MMP13 P45452 1/20 0.45
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
KDM4E B2RXH2 4/20 0.41
HSD17B10 Q99714 3/20 0.41
POLB P06746 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
HTT P42858 2/20 0.40
HRH4 Q9H3N8 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Urea SCHEMBL28780664 0.79 PLAU (0.48) GAAALDH1A1PLAUKDM4EHSD17B10
SCHEMBL5369135 0.78 CHEK1 (0.52) CHEK1ALDH1A1HTTCHEK2
SCHEMBL5203581 0.77 GAA (0.54) CHEK1GAAALDH1A1CYP3A4CYP2C19
SCHEMBL5374691 0.76 GAA (0.47) CHEK1GAAALDH1A1CHEK2
SCHEMBL5733402 0.76 SLC6A2 (0.44) CHEK1GAAMMP2MMP13CHEK2
SCHEMBL5733310 0.73 GAA (0.44) CHEK1GAAALDH1A1L3MBTL1KDM4E
SCHEMBL21898452 0.73 MAPT (0.51) GAAALDH1A1L3MBTL1PKMST14
SCHEMBL29684111 0.72 HRH3 (0.49) L3MBTL1PLAUKDM4EHSD17B10POLB
SCHEMBL1651087 0.72 MMP2 (0.66) ALDH1A1MMP2MMP13CYP2C19KDM4E
SCHEMBL2940750 0.72 HRH3 (0.49) L3MBTL1PLAUKDM4EHSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed